Morning Briefing
Summaries of health policy coverage from major news organizations
How Many Have Died From Covid? Toll May Be Triple The Confirmed Tally
Bloomberg: Covid Study Finds 18 Million Deaths, Three Times Official Tally
The pandemic’s death toll may be three times higher than official Covid-19 records suggest, according to a study that found stark differences across countries and regions. As many as 18.2 million people probably died from Covid in the first two years of the pandemic, researchers found in the first peer-reviewed global estimate of excess deaths. They pointed to a lack of testing and unreliable mortality data to explain the discrepancy with official estimates of roughly 5.9 million deaths. (Gale, 3/10)
USA Today: 'Very Sobering': Global Deaths From COVID May Be More Than 3 Times Higher Than Official Toll, Study Says
As the U.S. approaches the grim milestone of one million COVID-19 deaths, a team of researchers published the first peer-reviewed study looking at excess death estimates on a global scale. The results are alarming, health experts say. Excess deaths is the difference between the number of recorded deaths from all causes and the number of expected deaths based on past trends. Researchers at the University of Washington’s Institute of Health Metrics and Evaluation found an estimated 18.2 million people may have died by the end of 2021 due to the COVID-19 pandemic, more than three times the official toll of 5.9 million, according to the study published Thursday in The Lancet. (Rodriguez, 3/10)
In more news about covid cases —
Detroit Free Press: Michigan COVID-19 Death Rates By County: Education, Age, Trump Factors
Who died of COVID-19 in Michigan during the first two years of the coronavirus pandemic was heavily influenced by demographics like age, education level, the county where they lived, vaccination rates — and even who got their vote in the 2020 presidential election. As Michigan marked the grim two-year anniversary Thursday of the day when the first cases were identified, a Free Press analysis of state and federal data shows a higher death rate in counties where a larger share of people voted for Donald Trump in the 2020 presidential election. "I would expect to see significant correlation," said Peter Jacobson, professor emeritus of health law and policy at the University of Michigan School of Public Health. (Jordan Shamus and Tanner, 3/11)
The Boston Globe: Number Of COVID-19 Deaths In Mass. Will Drop Under State’s New Counting Method
The official count of COVID-19 deaths in Massachusetts will decline by about 3,700 under a new surveillance system that state health leaders say more accurately captures the true toll from the virus. “We think this is an absolutely critical step in improving our understanding of who COVID has impacted most significantly during the pandemic,” Dr. Catherine Brown, the state’s epidemiologist, said at a media briefing Thursday. Currently, the state’s reported confirmed and probable deaths total about 23,700. Under the new method, that could drop to about 20,000. But Brown said a team at the state’s health department is still crunching the numbers and would release them Monday. (Lazar, 3/10)
AP: Nevada Shifting To Weekly COVID Stats As Cases Keep Falling
State health officials are moving from daily to weekly reporting of COVID-19 statistics as the public health emergency fades and new infections and hospitalizations continue to fall to their lowest levels in Nevada since last June. Beginning next week, they’ll also be changing the way they track the spread and response to the coronavirus, including dropping regular reporting of positivity rates that are increasingly skewed due to widespread use of home-testing results. (Sonner, 3/10)
Crain's New York Business: NYC Says It Is Ready To Take On ‘Test To Treat' Initiative
Despite modest stockpiles of oral COVID treatments, New York City says it is ready to carry out the new federal initiative to treat patients who test positive on the spot. The Department of Health and Human Services on Tuesday outlined details for the "Test to Treat'' initiative, introduced by President Joe Biden in his State of the Union address last week. The program allows individuals who receive a positive COVID test result to receive treatment with antiviral pills on the spot. It kicked off Monday, and participating pharmacy-based clinics, federally qualified health centers and long-term-care facilities are eligible to receive direct distributions of molnupiravir and Paxlovid from HHS. Molnupiravir was developed by Merck and Ridgeback Biotherapeutics and Paxlovid comes from Pfizer. (Sim, 3/10)
